Sort   by:  
 Page size 
UnknownGraft Immune Cell Composition Associates with Clinical Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with AML.
Not available
S-EPMC5117118 | biostudies-literature
UnknownAntibody response to the 23-valent pneumococcal polysaccharide vaccine after conjugate vaccine in patients with chronic lymphocytic leukemia.
Not available
S-EPMC6930110 | biostudies-literature
UnknownEarly CD8+-recovery independently predicts low probability of disease relapse but also associates with severe GVHD after allogeneic HSCT.
Not available
S-EPMC6147489 | biostudies-literature
UnknownAntibody persistence after pneumococcal conjugate vaccination in patients with chronic lymphocytic leukemia.
Not available
S-EPMC6037466 | biostudies-literature
UnknownArpp19 Promotes Myc and Cip2a Expression and Associates with Patient Relapse in Acute Myeloid Leukemia.
Not available
S-EPMC6895887 | biostudies-literature
UnknownImmunomonitoring of MSC-Treated GvHD Patients Reveals Only Moderate Potential for Response Prediction but Indicates Treatment Safety.
Not available
S-EPMC5834657 | biostudies-literature
UnknownClinically relevant germline variants in allogeneic hematopoietic stem cell transplant recipients.
Not available
S-EPMC9812774 | biostudies-literature
UnknownImpact of CHEK2 germline variants on haematological malignancy risk and outcomes of allogeneic HSCT
Not available
S-EPMC12378959 | biostudies-literature
UnknownCNS Involvement at Initial Diagnosis and Risk of Relapse After Allogeneic HCT for Acute Lymphoblastic Leukemia in First Complete Remission.
Not available
S-EPMC9561382 | biostudies-literature
UnknownMeta-Analysis of Genome-Wide Association and Gene Expression Studies Implicates Donor T Cell Function and Cytokine Pathways in Acute GvHD.
Not available
S-EPMC7008714 | biostudies-literature
Sort   by:  
 Page size